Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Barbara Burtness MD
Barbara Burtness MD Advisory Board
Benjamin Anderson MD, FACS
Benjamin O. Anderson MD, FACS Advisory Board
Jean-Yves Douillard MD, PhD
Jean-Yves Douillard MD, PhD Advisory Board
See All Experts
featured
Published in Oncology

Expert Opinion / Interview · August 18, 2015

At What Point Does Cancer Treatment Cost Too Much? Part 2

Jarushka Naidoo MD
Jeffrey Kirshner MD, FACP, FASCO

 

 Save  Recommend
 Share

Additional Info

  1. Carey LA, Perou CM. Palbociclib--taking breast-cancer cells out of gear. N Engl J Med. 2015;373(3):273-274.
  2. Schnipper LE, Davidson NE, Wollins DS, et al. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options [published online ahead of print June 22, 2015]. J. Clin. Oncol. doi: 10.1200/JCO.2015.61.6706.

Further Reading

Most Read This Week

Recently Updated